Percutaneous intervention for atherosclerotic disease in saphenous vein grafts.
The long term benefit of coronary artery bypass surgery (CABG) is limited by development of atherosclerotic disease in the bypass conduits. Percutaneous revascularisation is frequently the preferred method of treated symptomatic saphenous vein graft (SVG) atherosclerotic disease. The immediate and long term results of percutaneous intervention for SVGs is reviewed. Therapeutic considerations as well as novel technical advances are overviewed
Mulvihill
Niall T
NT
Unite de Cardiologie Interventionnelle, Clinique Pasteur, 45 Avenue de Lombez, 31076, Toulouse, France. mulvihin@hotmail.com
Marco
Jean
J
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects* / Q000379:methods; D003324:Coronary Artery Disease / Q000628:therapy*; D023921:Coronary Stenosis / Q000601:surgery*; D005260:Female; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012501:Saphenous Vein / Q000637:transplantation*; D015996:Survival Rate; D016896:Treatment Outcome